Logo (Actavis) 2849 Logo (Actavis) 2849 Pill - green & white capsule/oblong, 19mm
Pill with imprint Logo (Actavis) 2849 Logo (Actavis) 2849 is Green & White, Capsule/Oblong and has been identified as Fluvoxamine Maleate Extended-Release 150 mg. It is supplied by Actavis Elizabeth LLC.
Fluvoxamine is used in the treatment of Obsessive Compulsive Disorder; Anxiety and Stress; Social Anxiety Disorder and belongs to the drug class selective serotonin reuptake inhibitors. Risk cannot be ruled out during pregnancy. Fluvoxamine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 2849 Logo (Actavis) 2849
Fluvoxamine Maleate Extended-Release
- Imprint
- Logo (Actavis) 2849 Logo (Actavis) 2849
- Strength
- 150 mg
- Color
- Green & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective serotonin reuptake inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 00228-2849
- Inactive Ingredients
-
ammonio methacrylate copolymer type A,
ammonio methacrylate copolymer type B,
ferrosoferric oxide,
FD&C Blue No. 1,
gelatin,
hydroxypropyl cellulose,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferric oxide yellow,
shellac,
propylene glycol,
potassium hydroxide,
sucrose,
corn starch
Note: Inactive ingredients may vary.
More about fluvoxamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (379)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: selective serotonin reuptake inhibitors
- Breastfeeding
- En español
Patient resources
- Fluvoxamine drug information
- Fluvoxamine (Advanced Reading)
- Fluvoxamine Tablets
- Fluvoxamine Extended-Release Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.